The medical community is buzzing about semaglutide, a compound initially developed for controlling type 2 diabetes. New research indicates that this GLP-1 receptor agonist demonstrates remarkable efficacy in promoting weight loss , potentially revolutionizing how we approach obesity . While not a mi